Skip to main content
Account

Peer review reports

From: The efficacy and potential mechanisms of pyrotinib in targeting EGFR and HER2 in advanced oral squamous cell carcinoma

Original Submission
10 Oct 2023 Submitted Original manuscript
23 Mar 2024 Reviewed Reviewer Report - Tahrir N. Aldelaimi
31 Mar 2024 Reviewed Reviewer Report - Manar Alnema
29 Apr 2024 Author responded Author comments - Huiming Wang
Resubmission - Version 2
29 Apr 2024 Submitted Manuscript version 2
29 Apr 2024 Author responded Author comments - Huiming Wang
Resubmission - Version 3
29 Apr 2024 Submitted Manuscript version 3
30 Apr 2024 Author responded Author comments - Huiming Wang
Resubmission - Version 4
30 Apr 2024 Submitted Manuscript version 4
30 Apr 2024 Reviewed Reviewer Report - Tahrir N. Aldelaimi
3 May 2024 Reviewed Reviewer Report - Manar Alnema
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
7 Jun 2024 Editorially accepted
6 Aug 2024 Article published 10.1186/s12903-024-04459-4

Learn about peer review

Back to article page

Navigation